Elinzanetant belongs to a new class of drugs designed to target what is believed to be a key mechanism responsible for ...
The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...
Antidepressants, a mainstay in treating depression and related mental health conditions, do not affect everyone in the same ...
A leading pharmacist has revealed three anti-depressant medications which leave patients struggling with 'terrible' ...
MedPage Today on MSN
Novel Nonhormonal Drug Approved for Menopause Hot Flashes
The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer ...
MedPage Today on MSN
Nurses Sue Over COVID Bonuses; Doc Sues School District; Ivermectin Reprimand
New Jersey orthopedic surgeon Michael Meese, MD, has sued a local school district for which he served as medical director for ...
Side effects of different antidepressants have been ranked for the first time, revealing huge differences between drugs.
On Friday, the FDA approved Bayer’s dual neurokinin (NK) targeted therapy elinzanetant, which will now be marketed in the U.S ...
A new study has ranked antidepressants by their physical side effects, revealing significant variations in weight change, ...
Study reveals how common antidepressants, such Fluoxetine, Sertraline and Citalopram, may impact your heart rate, cholesterol ...
Metoprolol is an effective treatment for the fast heart rate that some people get when they have anxiety, and metoprolol by ...
Generalized anxiety disorder affects millions, often trapping sufferers in cycles of fear and isolation that conventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results